US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
US5384253A
(en)
|
1990-12-28 |
1995-01-24 |
Dekalb Genetics Corporation |
Genetic transformation of maize cells by electroporation of cells pretreated with pectin degrading enzymes
|
WO1993004169A1
(en)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
US5702932A
(en)
|
1992-07-20 |
1997-12-30 |
University Of Florida |
Microinjection methods to transform arthropods with exogenous DNA
|
EP0710283A4
(en)
|
1993-07-22 |
1997-07-02 |
Merck & Co Inc |
THE EXPRESSION OF HUMAN INTERLEUKIN-1-g (b) IN A TRANSGENIC ANIMAL
|
US5656610A
(en)
|
1994-06-21 |
1997-08-12 |
University Of Southern California |
Producing a protein in a mammal by injection of a DNA-sequence into the tongue
|
US5736524A
(en)
|
1994-11-14 |
1998-04-07 |
Merck & Co.,. Inc. |
Polynucleotide tuberculosis vaccine
|
US5843780A
(en)
|
1995-01-20 |
1998-12-01 |
Wisconsin Alumni Research Foundation |
Primate embryonic stem cells
|
US5780448A
(en)
|
1995-11-07 |
1998-07-14 |
Ottawa Civic Hospital Loeb Research |
DNA-based vaccination of fish
|
GB9807935D0
(en)
|
1998-04-14 |
1998-06-10 |
Univ Edinburgh |
Lineage specific cells and progenitor cells
|
US5945100A
(en)
|
1996-07-31 |
1999-08-31 |
Fbp Corporation |
Tumor delivery vehicles
|
US5981274A
(en)
|
1996-09-18 |
1999-11-09 |
Tyrrell; D. Lorne J. |
Recombinant hepatitis virus vectors
|
ATE394484T1
(de)
|
1997-06-13 |
2008-05-15 |
Ludwig Inst Cancer Res |
Smad 6 und dessen anwendungen
|
US5994624A
(en)
|
1997-10-20 |
1999-11-30 |
Cotton Incorporated |
In planta method for the production of transgenic plants
|
US6214879B1
(en)
|
1998-03-24 |
2001-04-10 |
Virginia Commonwealth University |
Allosteric inhibitors of pyruvate kinase
|
US20060263382A1
(en)
|
1998-06-20 |
2006-11-23 |
Richard Hotchkiss |
Membrane-permeant peptide complexes for treatment of sepsis
|
EP1100872A1
(en)
|
1998-07-24 |
2001-05-23 |
Carnegie Institution Of Washington |
Method for maintenance and propagation of germline stem cells using members of the tgf-beta family of growth factors
|
DK1169312T3
(da)
|
1999-03-29 |
2005-01-31 |
Hoffmann La Roche |
Glucokinaseaktivatorer
|
CA2374269C
(en)
|
1999-05-20 |
2007-04-24 |
Humanetics Corporation |
Stimulating transport of glucose into animal tissue by the administration of pinitol
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
US6353111B1
(en)
|
1999-12-15 |
2002-03-05 |
Hoffmann-La Roche Inc. |
Trans olefinic glucokinase activators
|
US20020142457A1
(en)
|
1999-12-28 |
2002-10-03 |
Akihiro Umezawa |
Cell having the potentiality of differentiation into cardiomyocytes
|
AU7049401A
(en)
|
2000-05-03 |
2001-11-12 |
Hoffmann La Roche |
Alkynyl phenyl heteroaromatic glucokinase activators
|
BR0110492A
(pt)
|
2000-05-03 |
2003-04-08 |
Hoffmann La Roche |
Composto, composição farmacêutica que compreende esse composto, processo para a preparação de composição farmacêutica, utilização do composto e processo para a preparação do composto
|
WO2001085707A1
(en)
|
2000-05-08 |
2001-11-15 |
F. Hoffmann-La Roche Ag |
Para-amine substituted phenylamide glucokinase activators
|
DE60106599T2
(de)
|
2000-05-08 |
2006-02-09 |
F. Hoffmann-La Roche Ag |
Substituierte phenylacetamide und ihre verwendung als glukokinase aktivatoren
|
WO2002008209A1
(en)
|
2000-07-20 |
2002-01-31 |
F. Hoffmann-La Roche Ag |
Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
|
US6369232B1
(en)
|
2000-08-15 |
2002-04-09 |
Hoffmann-La Roche Inc. |
Tetrazolyl-phenyl acetamide glucokinase activators
|
PT1341774E
(pt)
|
2000-12-06 |
2006-05-31 |
Hoffmann La Roche |
Activadores heteroaromaticos, fundidos de glicocinase
|
US6482951B2
(en)
|
2000-12-13 |
2002-11-19 |
Hoffmann-La Roche Inc. |
Isoindolin-1-one glucokinase activators
|
DK1456380T3
(da)
|
2001-11-02 |
2012-07-30 |
Giuliani Int Ltd |
SMAD7-inhibitorer til behandling af CNS-sygdomme
|
EP1453541A1
(en)
|
2001-12-03 |
2004-09-08 |
Novo Nordisk A/S |
Use of a glucokinase activator in combination with a glucagon antagonist for treating type 2 diabetes
|
EP2324834B1
(en)
|
2001-12-06 |
2019-05-08 |
Fibrogen, Inc. |
Methods of Increasing Endogenous Erythropoietin (EPO)
|
GB0206711D0
(en)
|
2002-03-21 |
2002-05-01 |
Isis Innovation |
HIF Inhibitor
|
JP4091600B2
(ja)
|
2002-04-26 |
2008-05-28 |
エフ.ホフマン−ラ ロシュ アーゲー |
置換フェニルアセトアミド及びグルコキナーゼ活性化物質としてのその使用
|
GB0210539D0
(en)
|
2002-05-08 |
2002-06-19 |
Univ Edinburgh |
Control of es cell self renewal and lineage specification, and medium therefor
|
MY141521A
(en)
|
2002-12-12 |
2010-05-14 |
Hoffmann La Roche |
5-substituted-six-membered heteroaromatic glucokinase activators
|
ES2362656T3
(es)
|
2003-01-06 |
2011-07-11 |
Eli Lilly And Company |
Arilciclopropilacetamidas sustituidas como activadores de glucoquinasa.
|
WO2004072068A1
(en)
|
2003-02-10 |
2004-08-26 |
Amgen Inc. |
Vanilloid receptor ligands and their use in treatments
|
WO2004072066A1
(en)
|
2003-02-11 |
2004-08-26 |
Prosidion Limited |
Tri(cyclo) substituted amide glucokinase activator compounds
|
AU2003901099A0
(en)
|
2003-03-11 |
2003-03-27 |
Es Cell International Pte Ltd. |
Methods of inducing differentiation of stem cells
|
US20070010008A1
(en)
|
2005-06-29 |
2007-01-11 |
Tissuetech, Inc. |
Ex vivo expansion of primary animal cells
|
EP1732581A4
(en)
|
2003-06-20 |
2008-06-04 |
Univ California San Diego |
POLYPEPTIDE TRANSDUCTION AND FUSOGENIC PEPTIDES
|
CN103602633A
(zh)
|
2003-10-03 |
2014-02-26 |
福田惠一 |
由干细胞分化诱导心肌细胞的方法
|
NZ547105A
(en)
|
2003-10-16 |
2009-02-28 |
Univ Edinburgh |
Control of ES cell self-renewal and lineage specification, and medium therefor
|
AU2004291559B2
(en)
|
2003-11-19 |
2008-10-16 |
Australian Stem Cell Centre Limited |
Methods for producing blood products from pluripotent cells in cell culture
|
EP1532980A1
(en)
|
2003-11-24 |
2005-05-25 |
Novo Nordisk A/S |
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
|
US20070269412A1
(en)
|
2003-12-02 |
2007-11-22 |
Celavie Biosciences, Llc |
Pluripotent cells
|
DK1723128T3
(da)
|
2004-01-06 |
2013-02-18 |
Novo Nordisk As |
Heteroarylurinstoffer og deres anvendelse som glucokinaseaktivatorer
|
JP4700684B2
(ja)
|
2004-04-02 |
2011-06-15 |
ノバルティス アーゲー |
2型糖尿病の処置に有用なグルコキナーゼアクティベーターとしてのスルホンアミド−チアゾロピリジン誘導体
|
JP2008502658A
(ja)
|
2004-06-17 |
2008-01-31 |
ノボ ノルディスク アクティーゼルスカブ |
肝臓選択的グルコキナーゼ活性化因子の使用
|
MX2007001650A
(es)
|
2004-08-12 |
2007-07-13 |
Prosidion Ltd |
Fenilacetamidas substituidas y su uso como activadores de glucocinasa.
|
WO2006020919A2
(en)
|
2004-08-13 |
2006-02-23 |
University Of Georgia Research Foundation, Inc. |
Compositions and methods for self-renewal and differentiation in human embryonic stem cells
|
US20080268533A1
(en)
|
2004-08-25 |
2008-10-30 |
University Of Georgia Research Foundation, Inc. |
Methods and Compositions Utilizing Myc and Gsk3Beta to Manipulate the Pluripotency of Embryonic Stem Cells
|
CA2590720A1
(en)
|
2004-12-03 |
2006-06-08 |
Lone Jeppesen |
Heteroaromatic glucokinase activators
|
WO2006084210A2
(en)
|
2005-02-04 |
2006-08-10 |
Regents Of The University Of California, San Diego |
Hif modulating compounds and methods of use thereof
|
US20060182724A1
(en)
|
2005-02-15 |
2006-08-17 |
Riordan Neil H |
Method for expansion of stem cells
|
JP2009500378A
(ja)
|
2005-07-08 |
2009-01-08 |
ノボ・ノルデイスク・エー/エス |
グルコキナーゼ活性化剤としてのジシクロアルキルカルバモイル尿素
|
CA2614518A1
(en)
|
2005-07-08 |
2007-01-18 |
Novo-Nordisk A/S |
Dicycloalkyl urea glucokinase activators
|
JP4960355B2
(ja)
|
2005-07-14 |
2012-06-27 |
ノボ・ノルデイスク・エー/エス |
ウレア型グルコキナーゼ活性化剤
|
CN101313065A
(zh)
|
2005-08-01 |
2008-11-26 |
纽珀滕索有限公司 |
具有恢复的潜能的重编程序细胞的生产
|
WO2007030693A2
(en)
|
2005-09-08 |
2007-03-15 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Methods for promoting stem cell proliferation and survival
|
JP2009508832A
(ja)
|
2005-09-16 |
2009-03-05 |
アストラゼネカ アクチボラグ |
グルコキナーゼ活性化剤としてのヘテロ二環式化合物
|
WO2007048717A1
(en)
|
2005-10-24 |
2007-05-03 |
F. Hoffmann-La Roche Ag |
Preparation of cyclic, ketalized ketones by favorskii rearrangement and the use thereof for the preparation of glucokinase activator 70
|
JP5137207B2
(ja)
|
2005-11-01 |
2013-02-06 |
アレイ バイオファーマ、インコーポレイテッド |
グルコキナーゼ活性化因子
|
US20070197532A1
(en)
|
2005-11-18 |
2007-08-23 |
Cao Sheldon X |
Glucokinase activators
|
US20090227032A1
(en)
*
|
2005-12-13 |
2009-09-10 |
Kyoto University |
Nuclear reprogramming factor and induced pluripotent stem cells
|
EP4223769A3
(en)
|
2005-12-13 |
2023-11-01 |
Kyoto University |
Nuclear reprogramming factor
|
JP2009520825A
(ja)
|
2005-12-20 |
2009-05-28 |
武田薬品工業株式会社 |
グルコキナーゼ活性剤
|
ES2378704T3
(es)
|
2006-01-27 |
2012-04-17 |
Array Biopharma, Inc. |
Activadores de la glucocinasa
|
EP1992360A4
(en)
|
2006-02-01 |
2010-02-17 |
Univ Tokyo |
USE IN ASSOCIATION OF A TGF-BETA SIGNAL INHIBITOR AND ANTITUMMER AGENT
|
US7541186B2
(en)
|
2006-02-22 |
2009-06-02 |
University Of Washington |
Method of generating human retinal progenitors from embryonic stem cells
|
WO2007104034A2
(en)
|
2006-03-08 |
2007-09-13 |
Takeda San Diego, Inc. |
Glucokinase activators
|
RS53981B1
(en)
|
2006-03-24 |
2015-10-30 |
Array Biopharma Inc. |
2-AMINOPYRIDINE ANALYSIS AS GLUCOCINASE ACTIVATORS
|
GB0615327D0
(en)
|
2006-03-30 |
2006-09-13 |
Univ Edinburgh |
Culture medium containing kinase inhibitors and uses thereof
|
EP1999249B8
(en)
|
2006-03-30 |
2012-02-15 |
The University Court Of The University of Edinburgh |
Culture medium containing kinase inhibitors. and uses thereof
|
WO2007115967A1
(en)
|
2006-04-12 |
2007-10-18 |
F. Hoffmann-La Roche Ag |
Crystalline isopropanol solvate of glucokinase activator
|
WO2007115968A2
(en)
|
2006-04-12 |
2007-10-18 |
F. Hoffmann-La Roche Ag |
Process for the preparation of a glucokinase activator
|
EP2019823B1
(en)
|
2006-04-28 |
2010-11-24 |
TransTech Pharma, Inc. |
Benzamide glucokinase activators
|
US8741643B2
(en)
|
2006-04-28 |
2014-06-03 |
Lifescan, Inc. |
Differentiation of pluripotent stem cells to definitive endoderm lineage
|
EP2019824A2
(en)
|
2006-04-28 |
2009-02-04 |
Transtech Pharma, Inc. |
Benzamide glucokinase activators
|
GB2452186B
(en)
|
2006-05-02 |
2011-01-26 |
Wisconsin Alumni Res Found |
Method of differentiating stem cells into cells of the endoderm and pancreatic lineage
|
US8008332B2
(en)
|
2006-05-31 |
2011-08-30 |
Takeda San Diego, Inc. |
Substituted indazoles as glucokinase activators
|
CN101595107A
(zh)
|
2006-06-30 |
2009-12-02 |
先灵公司 |
能提高p53活性的有取代哌啶及其用途
|
US7910747B2
(en)
|
2006-07-06 |
2011-03-22 |
Bristol-Myers Squibb Company |
Phosphonate and phosphinate pyrazolylamide glucokinase activators
|
US7888504B2
(en)
|
2006-07-06 |
2011-02-15 |
Bristol-Myers Squibb Company |
Glucokinase activators and methods of using same
|
WO2008006583A1
(en)
|
2006-07-14 |
2008-01-17 |
Novartis Ag |
Pyrimidine derivatives as alk-5 inhibitors
|
EP2054079A4
(en)
*
|
2006-07-19 |
2009-12-23 |
Univ Florida |
COMPOSITIONS FOR THE PROGRAMMING OF A CELL AND APPLICATIONS THEREOF
|
EP2046755A2
(en)
|
2006-07-24 |
2009-04-15 |
F. Hoffmann-Roche AG |
Pyrazoles as glucokinase activators
|
GB0622395D0
(en)
|
2006-11-09 |
2006-12-20 |
Univ Cambridge Tech |
Methods relating to pluripotent cells
|
WO2008079787A2
(en)
|
2006-12-20 |
2008-07-03 |
Takeda San Diego, Inc. |
Glucokinase activators
|
WO2008074694A1
(en)
|
2006-12-20 |
2008-06-26 |
F. Hoffmann-La Roche Ag |
Crystallization of glucokinase activators
|
TW200831081A
(en)
|
2006-12-25 |
2008-08-01 |
Kyorin Seiyaku Kk |
Glucokinase activator
|
US8138185B2
(en)
|
2007-01-09 |
2012-03-20 |
Novo Nordisk A/S |
Urea glucokinase activators
|
AU2008204530B2
(en)
|
2007-01-11 |
2013-08-01 |
Vtv Therapeutics Llc |
Urea glucokinase activators
|
JP5419279B2
(ja)
|
2007-01-17 |
2014-02-19 |
ウィスコンシン アラムニ リサーチ ファンデーション |
改良された幹細胞の培養
|
US20100172883A1
(en)
|
2007-01-19 |
2010-07-08 |
Bruneau Benoit Gaetan |
Methods of generating cardiomyocytes
|
US8431713B2
(en)
|
2007-01-24 |
2013-04-30 |
Array Biopharma, Inc. |
2-aminopyridine derivatives as glucokinase activators
|
US9175260B2
(en)
|
2007-01-30 |
2015-11-03 |
TheUniversity of Georgia Research Foundation, Inc. |
Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (MMC)
|
EP2982744A1
(en)
*
|
2007-02-23 |
2016-02-10 |
Advanced Cell Technology, Inc. |
Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogrammed cells
|
EP2132225A4
(en)
|
2007-02-27 |
2010-06-09 |
Procell Therapeutics Inc |
COMBINED USE OF NANOG AND OCT4 PERMEABLE TO CELLS TO INCREASE SELF-RENEWAL AND DELETE DIFFERENTIATION OF STEM CELLS
|
JP5491871B2
(ja)
|
2007-02-28 |
2014-05-14 |
アドビナス セラピュティックス プライベート リミテッド |
グルコキナーゼ活性化因子としての2,2,2−三置換アセトアミド誘導体、その方法及び薬学的応用
|
BRPI0808267A2
(pt)
|
2007-03-07 |
2014-07-22 |
Kyorin Phamaceutical Co., Ltd |
"composto representado pela formula geral (1) ou um sal farmeceuticamente aceitável do mesmo; método para o tratamento ou prevenção de diabetes ; uso do composto; composição farmacêutica e composto representado pela formula geral (3)".
|
ES2703592T3
(es)
|
2007-03-07 |
2019-03-11 |
Mei Pharma Inc |
Combinación de agente anticancerígeno de bencimidazol y un segundo agente anticancerígeno
|
US8173645B2
(en)
|
2007-03-21 |
2012-05-08 |
Takeda San Diego, Inc. |
Glucokinase activators
|
CN101679405A
(zh)
|
2007-03-23 |
2010-03-24 |
阵列生物制药公司 |
作为葡萄糖激酶活性剂的2-氨基吡啶类似物
|
WO2008126932A2
(en)
|
2007-04-09 |
2008-10-23 |
Riken |
Epigenetical regulation of brain plasticity
|
EP2155720B1
(en)
|
2007-06-08 |
2013-07-17 |
Advinus Therapeutics Private Limited |
Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
|
US8648069B2
(en)
|
2007-06-08 |
2014-02-11 |
Abbvie Inc. |
5-substituted indazoles as kinase inhibitors
|
US8222285B2
(en)
|
2007-06-11 |
2012-07-17 |
Bristol-Myers Squibb Company |
1,3-dihydroxy substituted phenylamide glucokinase activators
|
JP2008307007A
(ja)
|
2007-06-15 |
2008-12-25 |
Bayer Schering Pharma Ag |
出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
|
DK3293256T3
(da)
|
2007-06-29 |
2019-08-12 |
Fujifilm Cellular Dynamics Inc |
Automatiseret fremgangsmåde og apparatur til dyrkning af embryonale stamceller
|
JP2010534722A
(ja)
|
2007-07-27 |
2010-11-11 |
ブリストル−マイヤーズ スクイブ カンパニー |
新規グルコキナーゼ活性化薬およびその使用方法
|
WO2009032456A2
(en)
|
2007-08-01 |
2009-03-12 |
Primegen Biotech Llc |
Non-viral delivery of transcription factors that reprogram human somatic cells into a stem cell-like state
|
WO2009022179A2
(en)
|
2007-08-14 |
2009-02-19 |
Astrazeneca Ab |
Glucokinase activators in the treatment of osteoarthritis
|
WO2009025781A1
(en)
|
2007-08-16 |
2009-02-26 |
Beth Israel Deaconess Medical Center |
Activators of pyruvate kinase m2 and methods of treating disease
|
ES2589122T3
(es)
|
2007-08-31 |
2016-11-10 |
Whitehead Institute For Biomedical Research |
Estimulación de la ruta de la Wnt en la reprogramación de células somáticas
|
EP3078662A1
(en)
|
2007-09-21 |
2016-10-12 |
Array Biopharma, Inc. |
Pyridin-2-yl-amino-1,2,4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
|
CN101827832B
(zh)
|
2007-10-08 |
2014-05-07 |
阿德维纳斯治疗私人有限公司 |
作为葡糖激酶活化剂的乙酰胺衍生物、其制备方法及医药应用
|
AU2008310097B2
(en)
|
2007-10-09 |
2013-05-16 |
Merck Patent Gmbh |
Pyridine derivatives useful as glucokinase activators
|
US8236824B2
(en)
|
2007-10-09 |
2012-08-07 |
MERCK Patent Gesellschaft mit beschränkter Haftung |
N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators
|
EP2096169B1
(en)
*
|
2007-10-31 |
2020-11-18 |
Kyoto University |
Nuclear reprogramming method
|
JP4604076B2
(ja)
|
2007-11-07 |
2010-12-22 |
国立大学法人静岡大学 |
燃料電池用電解質膜
|
WO2009073523A2
(en)
|
2007-11-29 |
2009-06-11 |
Children's Hospital Of Orange County |
De-differentiation of human cells
|
AU2008329563A1
(en)
|
2007-11-30 |
2009-06-04 |
Cytomatrix Pty Ltd |
Methods of inducing pluripotency involving Oct4 protein
|
US20110190729A1
(en)
|
2007-11-30 |
2011-08-04 |
Cytomatrix Pty Ltd |
Methods of inducing pluripotency involving sox2 protein
|
CN101896483B
(zh)
|
2007-12-20 |
2013-11-20 |
株式会社Lg生命科学 |
葡糖激酶激活剂和包含其作为活性成分的药物组合物
|
WO2009083553A1
(en)
|
2007-12-31 |
2009-07-09 |
Rheoscience A/S |
Azine compounds as glucokinase activators
|
WO2009096049A1
(ja)
*
|
2008-02-01 |
2009-08-06 |
Kyoto University |
人工多能性幹細胞由来分化細胞
|
WO2009106203A1
(en)
|
2008-02-25 |
2009-09-03 |
Merck Patent Gmbh |
Glucokinase activators
|
SG10201607710UA
(en)
*
|
2008-03-17 |
2016-11-29 |
Scripps Research Inst |
Combined chemical and genetic approaches for generation of induced pluripotent stem cells
|
US8258134B2
(en)
|
2008-04-16 |
2012-09-04 |
Hoffmann-La Roche Inc. |
Pyridazinone glucokinase activators
|
US7741327B2
(en)
|
2008-04-16 |
2010-06-22 |
Hoffmann-La Roche Inc. |
Pyrrolidinone glucokinase activators
|
EP2268809B1
(en)
*
|
2008-05-02 |
2019-02-06 |
Kyoto University |
Method of nuclear reprogramming
|
BRPI0912802A2
(pt)
|
2008-05-16 |
2015-10-13 |
Takeda San Diego Inc |
ativadores de glicoquinase
|
ES2587395T3
(es)
|
2008-06-04 |
2016-10-24 |
Cellular Dynamics International, Inc. |
Procedimientos para la producción de células IPS usando un enfoque no vírico
|
US20090317850A1
(en)
|
2008-06-20 |
2009-12-24 |
Tomoko Sunami |
Crystal Structure of Human 70KD Ribosomal Protein S6 Kinase 1 Kinase Domain
|
CA2695590C
(en)
*
|
2008-06-27 |
2018-01-09 |
Kyoto University |
Method of efficiently establishing induced pluripotent stem cells
|
DK2295538T3
(en)
*
|
2008-07-07 |
2015-12-21 |
Takara Bio Inc |
Process for producing a pluripotent stem cell
|
US8298825B1
(en)
|
2008-08-25 |
2012-10-30 |
The General Hospital Corporation |
TGF-beta receptor inhibitors to enhance direct reprogramming
|
EP2344458A1
(en)
|
2008-09-11 |
2011-07-20 |
Pfizer Inc. |
Heteroaryls amide derivatives and their use as glucokinase activators
|
SG160248A1
(en)
*
|
2008-09-18 |
2010-04-29 |
Agency Science Tech & Res |
Use of novel monoclonal antibodies targeting human embryonic stem cells to characterize and kill induced pluripotent stem cells
|
US8841305B2
(en)
|
2008-10-09 |
2014-09-23 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Activators of the human pyruvate kinase M2 receptor
|
WO2010056767A1
(en)
|
2008-11-14 |
2010-05-20 |
Fibrogen, Inc. |
Thiochromene derivatives as hip hydroxylase inhibitors
|
CA2747398C
(en)
|
2008-12-17 |
2023-06-20 |
The Scripps Research Institute |
Generation and maintenance of stem cells
|
UA104742C2
(uk)
|
2008-12-19 |
2014-03-11 |
Эли Лилли Энд Компани |
Похідні арилциклопропілацетаміду, застосовні як активатори глюкокінази
|
US20120122212A1
(en)
|
2009-03-06 |
2012-05-17 |
Marica Grskovic |
Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
|
EP2406230A1
(en)
|
2009-03-11 |
2012-01-18 |
Pfizer Inc. |
Substituted indazole amides and their use as glucokinase activators
|
WO2010137348A1
(en)
|
2009-05-29 |
2010-12-02 |
Keio University |
Method for selecting clone of induced pluripotent stem cells
|
US8900871B2
(en)
|
2009-08-07 |
2014-12-02 |
Kyoto University |
Method of producing induced pluripotent stem cells using inhibitors of P53
|
WO2011047300A1
(en)
|
2009-10-16 |
2011-04-21 |
The Scripps Research Institute |
Induction of pluripotent cells
|
CN102844428B
(zh)
|
2010-03-05 |
2015-09-02 |
德克萨斯心脏研究所 |
Ets2和mesp1由成纤维细胞生成心脏祖细胞
|
EP3936608A1
(en)
*
|
2010-03-31 |
2022-01-12 |
The Scripps Research Institute |
Reprogramming cells
|